The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Abstract
Research in Parkinson's disease (PD) genetics has been extremely prolific over the past decade. More than 13 loci and 9 genes have been identified, but their implication in PD is not always certain. Point mutations, duplications and triplications in the alpha-synuclein (SNCA) gene cause a rare dominant form of PD in familial and sporadic cases. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a more frequent cause of autosomal dominant PD, particularly in certain ethnic groups. Loss-of-function mutations in Parkin, PINK1, DJ-1 and ATP13A2 cause autosomal recessive parkinsonism with early-onset. Identification of other Mendelian forms of PD will be a main challenge for the next decade. In addition, susceptibility variants that contribute to PD have been identified in several populations, such as polymorphisms in the SNCA, LRRK2 genes and heterozygous mutations in the beta-glucocerebrosidase (GBA) gene. Genome-wide associations and re-sequencing projects, together with gene-environment interaction studies, are expected to further define the causal role of genetic determinants in the pathogenesis of PD, and improve prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Self-citationRamirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Self-citationNon‐motor symptoms in Parkinson’s disease
Poewe, W. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02056.x · Cited by 782
A common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
(2004) · doi:10.1002/ana.10846 · Cited by 614
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Müller, T., Bornemann, A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi215 · Cited by 568
The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
Pan, T., Kondo, S., Le, W., & Jankovic, J. (2008) · Brain · doi:10.1093/brain/awm318 · Cited by 546
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron
Morgan, N. V., Westaway, S. K., Morton, J. E. V., Gregory, A., Gissen, P., Sonek, S., Cangul, H., Coryell, J., Canham, N., Nardocci, N., et al. (2006) · Nature Genetics · doi:10.1038/ng1826 · Cited by 533
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
High-Resolution Whole-Genome Association Study of Parkinson Disease
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Strain, K. J., Farrer, M. J., Rocca, W. A., Pant, P. V. K., Frazer, K. A., Cox, D. R., & Ballinger, D. G. (2005) · The American Journal of Human Genetics · doi:10.1086/496902 · Cited by 508
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs
Lesage, S., Dürr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., & Brice, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055540 · Cited by 494
Self-citationCharacterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1644 · Cited by 479
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Gasser, T., Müller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P., & Horstmann, R. D. (1998) · Nature Genetics · doi:10.1038/ng0398-262 · Cited by 458
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
Neuropathology provides clues to the pathophysiology of Gaucher disease
Wong, K., Sidransky, E., Verma, A., Mixon, T., Sandberg, G. D., Wakefield, L. K., Morrison, A., Lwin, A., Colegial, C., Allman, J. M., et al. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.011 · Cited by 452
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C., Pugh, E. W., Doheny, K. F., Gusella, J. F., Nichols, W. C., Foroud, T., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 443
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
Fuchs, J., Nilsson, C., Kachergus, J., Munz, M., Larsson, E.-M., Schüle, B., Langston, J. W., Middleton, F. A., Ross, O. A., Hulihan, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254458.17630.c5 · Cited by 397
Martins, L. M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., Grau, E., Geppert, M., Livi, G. P., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9848-9862.2004 · Cited by 394
Fung, H.-C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Britton, A., Gibbs, J. R., Langefeld, C., Stiegert, M. L., Schymick, J., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70578-6 · Cited by 389
Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice
Jones, J. M., Datta, P., Srinivasula, S. M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnóczky, G., Saunders, T. L., Van Keuren, M. L., et al. (2003) · Nature · doi:10.1038/nature02052 · Cited by 377
Glucocerebrosidase mutations in subjects with parkinsonism
Lwin, A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.11.004 · Cited by 371
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
Fonzo, A. D., Dekker, M. C. J., Montagna, P., Baruzzi, A., Yonova, E. H., Guedes, L. C., Szczerbinska, A., Zhao, T., Dubbel-Hulsman, L. O. M., Wouters, C. H., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338144.10967.2b · Cited by 364
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Gan-Or, Z., Giladi, N., Rozovski, U., Shifrin, C., Rosner, S., Gurevich, T., Bar-Shira, A., & Orr-Urtreger, A. (2008) · Neurology · doi:10.1212/01.wnl.0000304039.11891.29 · Cited by 360
Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
Genomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
alpha-synuclein gene haplotypes are associated with Parkinson's disease
Farrer, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1847 · Cited by 340
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease
Di Fonzo, A., Chien, H. F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., Fabbrini, G., Marconi, R., Fincati, E., Abbruzzese, G., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000260963.08711.08 · Cited by 339
Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., et al. (2005) · Brain · doi:10.1093/brain/awh667 · Cited by 317
Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
Nishioka, K., Hayashi, S., Farrer, M. J., Singleton, A. B., Yoshino, H., Imai, H., Kitami, T., Sato, K., Kuroda, R., Tomiyama, H., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20753 · Cited by 316
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
Klein, C., Lohmann-Hedrich, K., Rogaeva, E., Schlossmacher, M. G., & Lang, A. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70174-6 · Cited by 309
Neurodegeneration associated with genetic defects in phospholipase A 2
Gregory, A., Westaway, S. K., Holm, I. E., Kotzbauer, P. T., Hogarth, P., Sonek, S., Coryell, J. C., Nguyen, T. M., Nardocci, N., Zorzi, G., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000327094.67726.28 · Cited by 270
Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
Goris, A., Williams‐Gray, C. H., Clark, G. R., Foltynie, T., Lewis, S. J. G., Brown, J., Ban, M., Spillantini, M. G., Compston, A., Burn, D. J., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21192 · Cited by 270
Interface between tauopathies and synucleinopathies: A tale of two proteins
Galpern, W. R., & Lang, A. E. (2006) · Annals of Neurology · doi:10.1002/ana.20819 · Cited by 263
Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*
Berg, D., Schweitzer, K. J., Leitner, P., Zimprich, A., Lichtner, P., Belcredi, P., Brüssel, T., Schulte, C., Maass, S., Nägele, T., et al. (2005) · Brain · doi:10.1093/brain/awh666 · Cited by 261
A susceptibility gene for late‐onset idiopathic Parkinson's disease
Hicks, A. A., Pétursson, H., Jónsson, T., Stefánsson, H., Jóhannsdóttir, H. S., Sainz, J., Frigge, M. L., Kong, A., Gulcher, J. R., Stefánsson, K., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10324 · Cited by 260
MUTATIONS IN GBA ARE ASSOCIATED WITH FAMILIAL PARKINSON DISEASE SUSCEPTIBILITY AND AGE AT ONSET
Sidransky, E., Samaddar, T., & Tayebi, N. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b28601 · Cited by 259
Genome-wide Linkage Analysis of a Parkinsonian-Pyramidal Syndrome Pedigree by 500 K SNP Arrays
Shojaee, S., Sina, F., Banihosseini, S. S., Kazemi, M. H., Kalhor, R., Shahidi, G.-A., Fakhrai-Rad, H., Ronaghi, M., & Elahi, E. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.05.005 · Cited by 258
Molecular and Clinical Correlations in Spinocerebellar Ataxia 2: A Study of 32 Families
Cancel, G., Durr, A., Didierjean, O., Imbert, G., Burk, K., Lezin, A., Belal, S., Benomar, A., Abada-Bendib, M., Vial, C., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.5.709 · Cited by 254
Self-citationMutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease
Clark, L. N., Ross, B. M., Wang, Y., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., Waters, C., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000276989.17578.02 · Cited by 252
α-Synuclein gene duplication is present in sporadic Parkinson disease
Ahn, T. B., Kim, S. Y., Kim, J. Y., Park, S. S., Lee, D. S., Min, H. J., Kim, Y. K., Kim, S. E., Kim, J. M., Kim, H. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000271080.53272.c7 · Cited by 249
Chiba-Falek, O. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3101 · Cited by 242
Multiple regions of α‐synuclein are associated with Parkinson's disease
Mueller, J. C., Fuchs, J., Hofer, A., Zimprich, A., Lichtner, P., Illig, T., Berg, D., Wüllner, U., Meitinger, T., & Gasser, T. (2005) · Annals of Neurology · doi:10.1002/ana.20438 · Cited by 234
Lrrk2 pathogenic substitutions in Parkinson's disease
Mata, I. F., Kachergus, J. M., Taylor, J. P., Lincoln, S., Aasly, J., Lynch, T., Hulihan, M. M., Cobb, S. A., Wu, R.-M., Lu, C.-S., et al. (2005) · Neurogenetics · doi:10.1007/s10048-005-0005-1 · Cited by 231
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
Goker-Alpan, O., Giasson, B. I., Eblan, M. J., Nguyen, J., Hurtig, H. I., Lee, V. M.-Y., Trojanowski, J. Q., & Sidransky, E. (2006) · Neurology · doi:10.1212/01.wnl.0000230215.41296.18 · Cited by 230
Di Fonzo, A., Wu-Chou, Y.-H., Lu, C.-S., van Doeselaar, M., Simons, E. J., Rohé, C. F., Chang, H.-C., Chen, R.-S., Weng, Y.-H., Vanacore, N., et al. (2006) · Neurogenetics · doi:10.1007/s10048-006-0041-5 · Cited by 229
Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome
Al-Din, A. S., Wriekat, A., Mubaidin, A., Dasouki, M., & Hiari, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb02645.x · Cited by 220
α‐Synuclein promoter confers susceptibility to Parkinson's disease
Pals, P., Lincoln, S., Manning, J., Heckman, M., Skipper, L., Hulihan, M., Van den Broeck, M., De Pooter, T., Cras, P., Crook, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20268 · Cited by 212
G2019S LRRK2 mutation in French and North African families with Parkinson's disease
Lesage, S., Ibanez, P., Lohmann, E., Pollak, P., Tison, F., Tazir, M., Leutenegger, A., Guimaraes, J., Bonnet, A., Agid, Y., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20636 · Cited by 212
Self-citationGlucocerebrosidase Gene Mutations: A Risk Factor for Lewy Body Disorders
Mata, I. F., Samii, A., Schneer, S. H., Roberts, J. W., Griffith, A., Leis, B. C., Schellenberg, G. D., Sidransky, E., Bird, T. D., Leverenz, J. B., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.68 · Cited by 207
Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl030 · Cited by 207
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Farrer, M. J., Stone, J. T., Lin, C.-H., Dächsel, J. C., Hulihan, M. M., Haugarvoll, K., Ross, O. A., & Wu, R.-M. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.12.001 · Cited by 205
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
Ross, O. A., Wu, Y., Lee, M., Funayama, M., Chen, M., Soto, A. I., Mata, I. F., Lee‐Chen, G., Chen, C. M., Tang, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21405 · Cited by 196
LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study
Hulihan, M. M., Ishihara-Paul, L., Kachergus, J., Warren, L., Amouri, R., Elango, R., Prinjha, R. K., Upmanyu, R., Kefi, M., Zouari, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70116-9 · Cited by 190
Whitworth, A. J., Lee, J. R., Ho, V. M.-W., Flick, R., Chowdhury, R., & McQuibban, G. A. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000109 · Cited by 189
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Rudolph, A., Shults, C., Conneally, P. M., & Foroud, T. (2002) · The American Journal of Human Genetics · doi:10.1086/341282 · Cited by 183
Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease
Lautier, C., Goldwurm, S., Dürr, A., Giovannone, B., Tsiaras, W. G., Pezzoli, G., Brice, A., & Smith, R. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.015 · Cited by 178
Self-citationComprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
The Italian Parkinson Genetics Network, Di Fonzo, A., Tassorelli, C., De Mari, M., Chien, H. F., Ferreira, J., Rohé, C. F., Riboldazzi, G., Antonini, A., Albani, G., et al. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201539 · Cited by 174
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
Clark, L. N., Wang, Y., Karlins, E., Saito, L., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000244345.49809.36 · Cited by 173
Ibáñez, P., Lesage, S., Janin, S., Lohmann, E., Durif, F., Destée, A., Bonnet, A.-M., Brefel‐Courbon, C., Heath, S. C., Zélénika, D., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.555 · Cited by 173
Self-citationAre interrupted SCA2 CAG repeat expansions responsible for parkinsonism?
Charles, P., Camuzat, A., Benammar, N., Sellal, F., Destée, A., Bonnet, A.-M., Lesage, S., Le Ber, I., Stevanin, G., Dürr, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000269323.21969.db · Cited by 166
Self-citationPresent and future drug treatment for Parkinson's disease
Schapira, A. H. V. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.035980 · Cited by 163
Significant Linkage of Parkinson Disease to Chromosome 2q36-37
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Rudolph, A., Shults, C., Conneally, P. M., & Foroud, T. (2003) · The American Journal of Human Genetics · doi:10.1086/374383 · Cited by 161
The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence
Tan, E. K., Zhao, Y., Skipper, L., Tan, M. G., Di Fonzo, A., Sun, L., Fook-Chong, S., Tang, S., Chua, E., Yuen, Y., et al. (2007) · Human Genetics · doi:10.1007/s00439-006-0268-0 · Cited by 160
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
Tan, E., Shen, H., Tan, L. C. S., Farrer, M. J., Yew, K., Chua, E., Jamora, R. D. G., Puvan, K., Puong, K. Y., Zhao, Y., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.103 · Cited by 155
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease
Orr‐Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Bar‐Shira, A., & Giladi, N. (2007) · Neurology · doi:10.1212/01.wnl.0000277637.33328.d8 · Cited by 155
Patients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia
Ikeuchi, T., Kakita, A., Shiga, A., Kasuga, K., Kaneko, H., Tan, C., Idezuka, J., Wakabayashi, K., Onodera, O., Iwatsubo, T., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.514 · Cited by 154
Hampshire, D. J., Roberts, E., Crow, Y. J., Bond, J., Mubaidin, A., Wriekat, A.-L., Al-Din, A., & Woods, C. G. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.10.680 · Cited by 153
LRRK2 mutations in Parkinson disease
Farrer, M. J., Stone, J., Mata, I. F., Lincoln, S. J., Kachergus, J. M., Hulihan, M., Strain, K. J., & Maraganore, D. M. (2005) · Neurology · doi:10.1212/01.wnl.0000169023.51764.b0 · Cited by 153
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Murrell, J., Rudolph, A., Shults, C. W., Conneally, P. M., & Foroud, T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg270 · Cited by 151
Lesage, S., Leutenegger, A., Ibáñez, P., Janin, S., Lohmann, E., Dürr, A., & Brice, A. (2005) · The American Journal of Human Genetics · doi:10.1086/432422 · Cited by 135
Self-citationProfile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2)
Furtado, S., Payami, H., Lockhart, P. J., Hanson, M., Nutt, J. G., Singleton, A., Singleton, A., Bower, J., Utti, R. J., Bird, T. D., et al. (2004) · Movement Disorders · doi:10.1002/mds.20074 · Cited by 132
Evaluation of LRRK2 G2019S penetrance
Goldwurm, S., Zini, M., Mariani, L., Tesei, S., Miceli, R., Sironi, F. M., Clementi, M., Bonifati, V., & Pezzoli, G. (2007) · Neurology · doi:10.1212/01.wnl.0000254483.19854.ef · Cited by 132
Zabetian, C. P., Hutter, C. M., Yearout, D., Lopez, A. N., Factor, S. A., Griffith, A., Leis, B. C., Bird, T. D., Nutt, J. G., Higgins, D. S., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/508025 · Cited by 131
The utility F-box for protein destruction
Ho, M. S.-C., Ou, C.-Y., Chan, Y., Chien, C., & Pi, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7592-6 · Cited by 131
Funayama, M., Li, Y., Tomiyama, H., Yoshino, H., Imamichi, Y., Yamamoto, M., Murata, M., Toda, T., Mizuno, Y., & Hattori, N. (2007) · Neuroreport · doi:10.1097/wnr.0b013e32801254b6 · Cited by 131
Bogaerts, V., Nuytemans, K., Reumers, J., Pals, P., Engelborghs, S., Pickut, B. A., Corsmit, E., Peeters, K., Schymkowitz, J. W. H., Deyn, P. P. D., et al. (2008) · Human Mutation · doi:10.1002/humu.20713 · Cited by 131
Simón‐Sánchez, J., & Singleton, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn096 · Cited by 131
Analysis of the glucocerebrosidase gene in Parkinson's disease
Sato, C., Morgan, A. R., Lang, A. E., Salehi‐Rad, S., Kawarai, T., Meng, Y., Ray, P. N., Farrer, L. A., George‐Hyslop, P. S., & Rogaeva, E. A. (2004) · Movement Disorders · doi:10.1002/mds.20319 · Cited by 125
Giovannone, B., Lee, E.-H., Laviola, L., Giorgino, F., Cleveland, K., & Smith, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211572200 · Cited by 125
Importance of Low-Range CAG Expansion and CAA Interruption in SCA2 Parkinsonism
Kim, J., Hong, S. N., Kim, Y., Choi, Y. J., Kim, Y. K., Park, S. S., Kim, S. E., & Jeon, B. S. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1510 · Cited by 125
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal
Brás, J., Paisán‐Ruiz, C., Guerreiro, R. J., Ribeiro, M. H., Morgadinho, A., Januário, C., Sidransky, E., Oliveira, C. R., & Singleton, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.016 · Cited by 117
Paisán‐Ruiz, C., Nath, P., Washecka, N., Gibbs, J. R., & Singleton, A. (2008) · Human Mutation · doi:10.1002/humu.20668 · Cited by 108
Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease
Ziegler, S. G., Eblan, M. J., Gutti, U., Hruska, K. S., Stubblefield, B. K., Göker-Alpan, Ö., LaMarca, M. E., & Sidransky, E. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.004 · Cited by 107
Latourelle, J. C., Sun, M., Lew, M., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R. L., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-32 · Cited by 105
Ishihara, L., Warren, L. L., Gibson, R. A., Amouri, R., Lesage, S., Dürr, A., Tazir, M., Wszołek, Z. K., Uitti, R. J., Nichols, W. C., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1250 · Cited by 103
Self-citationAnalysis of PARK genes in a Korean cohort of early-onset Parkinson disease
Choi, J. M., Woo, M. S., Ma, H., Kang, S. Y., Sung, Y. H., Yong, S. W., Chung, S. J., Kim, J., Shin, H., Lyoo, C. H., et al. (2008) · Neurogenetics · doi:10.1007/s10048-008-0138-0 · Cited by 101
Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore
Lin, C., Tan, E., Chen, M., Tan, L., Lim, H., Chen, G. S., & Wu, R. (2008) · Neurology · doi:10.1212/01.wnl.0000335167.72412.68 · Cited by 101
SCA2 may present as levodopa‐responsive parkinsonism
Payami, H., Nutt, J. G., Gancher, S., Bird, T. D., McNeal, M. G., Seltzer, W. K., Hussey, J., Lockhart, P. J., Gwinn, K. A., Singleton, A., et al. (2002) · Movement Disorders · doi:10.1002/mds.10375 · Cited by 100
Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population
Toft, M., Pielsticker, L. K., Ross, O. A., Aasly, J. O., & Farrer, M. J. (2006) · Neurology · doi:10.1212/01.wnl.0000196492.80676.7c · Cited by 98
PARK9 -LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE
Ning, Y., Kanai, K., Tomiyama, H., Li, Y., Funayama, M., Yoshino, H., Sato, S., Asahina, M., Kuwabara, S., Takeda, A., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000310427.72236.68 · Cited by 96
The Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Eblan, M. J., Walker, J. M., & Sidransky, E. (2005) · New England Journal of Medicine · doi:10.1056/nejm200502173520719 · Cited by 96
Ishihara, L., Gibson, R. A., Warren, L. L., Amouri, R., Lyons, K. E., Wielinski, C. L., Hunter, C., Swartz, J., Elango, R., Akkari, P. A., et al. (2006) · Movement Disorders · doi:10.1002/mds.21180 · Cited by 93
Wu, Y., Chen, C., Chao, C.-Y., Ro, L.-S., Lyu, R.-K., Chang, K., & Lee-Chen, G.-J. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.105940 · Cited by 90
CLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Obi, T., Nishioka, K., Ross, O. A., Terada, T., Yamazaki, K., Sugiura, A., Takanashi, M., Mizoguchi, K., Mori, H., Mizuno, Y., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000299387.59159.db · Cited by 85
Meta-Analysis in Genome-Wide Association Datasets: Strategies and Application in Parkinson Disease
Εvangelou, Ε., Maraganore, D. M., & Ioannidis, J. P. A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000196 · Cited by 84
Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy
Marco, E. V. D., Annesi, G., Tarantino, P., Rocca, F. E., Provenzano, G., Civitelli, D., Candiano, I. C. C., Annesi, F., Carrideo, S., Condino, F., et al. (2007) · Movement Disorders · doi:10.1002/mds.21892 · Cited by 83
Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease
Tan, E., Chai, A., Teo, Y., Zhao, Y., Tan, C. E., Shen, H., Chandran, V. R., Teoh, M. L., Yih, Y., Pavanni, R., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000101721.25345.dc · Cited by 82
Cookson, M., Xiromerisiou, G., & Singleton, A. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000186841.43505.e6 · Cited by 81
Lu, C.-S., Simons, E. J., Wu‐Chou, Y., et al. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.09.003 · Cited by 78
Mutations in the glucocerebrosidase gene and Parkinson disease: Phenotype–genotype correlation
Aharon‐Peretz, J., Badarny, S., Rosenbaum, H., & Gershoni‐Baruch, R. (2005) · Neurology · doi:10.1212/01.wnl.0000176987.47875.28 · Cited by 76
An, X., Peng, R., Li, T., et al. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02052.x · Cited by 76
Escaping Parkinson's disease: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
Kay, D. M., Kramer, P., Higgins, D. S., Zabetian, C. P., & Payami, H. (2005) · Movement Disorders · doi:10.1002/mds.20618 · Cited by 76
Genetic variation of Omi/HtrA2 and Parkinson's disease
Ross, O. A., Soto, A. I., Vilariño‐Güell, C., Heckman, M. G., Diehl, N. N., Hulihan, M., Aasly, J. O., Sando, S. B., Gibson, J. M., Lynch, T., et al. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.08.003 · Cited by 75
Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients
Berg, D., Niwar, M., Maaß, S., Zimprich, A. A., Möller, J. C., Wüllner, U., Schmitz‐Hübsch, T., Klein, C., Tan, E., Schöls, L. J., et al. (2005) · Movement Disorders · doi:10.1002/mds.20504 · Cited by 75
The Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease
Ki, C., Stavrou, E., Davanos, Ν., Lee, W., Chung, E., Kim, J., & Athanassiadou, A. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00781.x · Cited by 73
Okubadejo, N. U., Britton, A. F., Crews, C. K., Akinyemi, R., Hardy, J., Singleton, A., & Brás, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003421 · Cited by 71
Genetic anticipation in Parkinson's disease
Payami, H., Bernard, S., Larsen, K., Kaye, J., & Nutt, J. (1995) · Neurology · doi:10.1212/wnl.45.1.135 · Cited by 71
Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan
Izumi, Y., Morino, H., Oda, M., Maruyama, H., Udaka, F., Kameyama, M., Nakamura, S., & Kawakami, H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01557-9 · Cited by 68
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8
Nichols, W. C., Elsaesser, V. E., Pankratz, N., Pauciulo, M. W., Marek, D. K., Halter, C. A., Rudolph, A., Shults, C. W., & Foroud, T. (2007) · Neurology · doi:10.1212/01.wnl.0000278115.50741.4e · Cited by 67
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations
Chen‐Plotkin, A. S., Yuan, W., Anderson, C., Wood, E. M., Hurtig, H. I., Clark, C. M., Miller, B. L., Lee, V. M.-Y., Trojanowski, J. Q., Grossman, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000280574.17166.26 · Cited by 67
Association between Parkinson's disease and glucocerebrosidase mutations in Brazil
Spitz, M., Rozenberg, R., Pereira, L. V., & Barbosa, E. R. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.06.010 · Cited by 65
Beyond Parkinson Disease: Amyotrophic Lateral Sclerosis and the Axon Guidance Pathway
Lesnick, T. G., Sorenson, E. J., Ahlskog, J. E., Henley, J. R., Shehadeh, L. A., Papapetropoulos, S., & Maraganore, D. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001449 · Cited by 64
Lack of replication of association between GIGYF2 variants and Parkinson disease
Brás, J., Simón‐Sánchez, J., Federoff, M., Morgadinho, A., Januário, C., Ribeiro, M., Cunha, L., Oliveira, C. R., & Singleton, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn340 · Cited by 64
Digenic parkinsonism: Investigation of the synergistic effects of PRKN and LRRK2
Dächsel, J. C., Mata, I. F., Ross, O. A., Taylor, J. P., Lincoln, S., Hinkle, K. M., Huerta, C., Ribacoba, R., Estrada, M. B., Álvarez, V., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.06.068 · Cited by 60
Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease
Zabetian, C. P., Morino, H., Ujike, H., Yamamoto, M., Oda, M., Maruyama, H., Izumi, Y., Kaji, R., Griffith, A., Leis, B. C., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000227732.37801.d4 · Cited by 60
LRRK2 R1628P increases risk of Parkinson’s disease: replication evidence
Tan, E., Tan, L. C. S., Lim, H., Li, R., Tang, M., Yih, Y., Pavanni, R., Prakash, K. M., Fook-Chong, S. M. C., & Zhao, Y. (2008) · Human Genetics · doi:10.1007/s00439-008-0544-2 · Cited by 59
Lin, C., Tzen, K., Yu, C.-Y., Tai, C., Farrer, M. J., & Wu, R. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9260-0 · Cited by 58
The LRRK2 Arg1628Pro variant is a risk factor for Parkinson’s disease in the Chinese population
Lu, C.-S., Chou, Y. W., van Doeselaar, M., Simons, E. J., Chang, H., Breedveld, G. J., Fonzo, A. D., Chen, R., Weng, Y.-H., Lai, S., et al. (2008) · Neurogenetics · doi:10.1007/s10048-008-0140-6 · Cited by 57
CORTICOBASAL SYNDROME AND PRIMARY PROGRESSIVE APHASIA AS MANIFESTATIONS OF LRRK2 GENE MUTATIONS
Ross, O. A., Toft, M., & Haugarvoll, K. (2008) · Neurology · doi:10.1212/01.wnl.0000320511.30222.dd · Cited by 57
Socal, M., Emmel, V. E., Rieder, C., Hilbig, A., Saraiva-Pereira, M., & Jardim, L. B. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.09.005 · Cited by 56
New Genetic Insights into Parkinson's Disease
Feany, M. Β. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048263 · Cited by 56
Holzmann, C., Krüger, R., Vieira-Saecker, A. M. M., Schmitt, I., Schöls, L. J., Berger, K., & Rieß, O. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0769-5 · Cited by 54
Xiromerisiou, G., Hadjigeorgiou, G. M., Gourbali, V., Johnson, J. O., Papakonstantinou, I. P., Papadimitriou, A., & Singleton, A. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01551.x · Cited by 53
The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease
Cao, L. H., Zhang, T., Xiao, Q., Wang, Y., Bai, L., Lu, G., Fang, J., Zhang, J., Ding, J. Q., & Chen, S. D. (2007) · Movement Disorders · doi:10.1002/mds.21763 · Cited by 53
α-Synuclein, pesticides, and Parkinson disease
Brighina, L., Frigerio, R., Schneider, N., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304049.31377.f2 · Cited by 48
Belin, A. C., Westerlund, M., Sydow, O., Lundströmer, K., Håkansson, A. S., Nissbrandt, H., Olson, L., & Galter, D. (2006) · Movement Disorders · doi:10.1002/mds.21016 · Cited by 43
Simón‐Sánchez, J., Hanson, M., Singleton, A., Hernandez, D. G., McInerney-Leo, A. M., Nussbaum, R. L., Werner, J. S., Gallardo, M., Weiser, R., Gwinn, K. A., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.015 · Cited by 43
Warren, L. L., Gibson, R. A., Ishihara, L., Elango, R., Xue, Z., Akkari, P. A., Ragone, L. J., Pahwa, R., Jankovic, J. J., NANCE, M. A., et al. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.02.001 · Cited by 42
Glucosidase-beta variations and Lewy body disorders
Farrer, M. J., Williams, L. N., Algom, A. A., Kachergus, J. M., Hulihan, M., Ross, O. A., Rajput, A. H., Papapetropoulos, S., Mash, D. C., & Dickson, D. W. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.08.004 · Cited by 42
Shan, D., Liu, R., Sun, C., Lee, S., Liao, K., & Soong, B. (2004) · Movement Disorders · doi:10.1002/mds.20212 · Cited by 39
α-Synuclein gene duplication is present in sporadic Parkinson disease
Brueggemann, N., Odin, P., Gruenewald, A., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000338439.00992.c7 · Cited by 36
PROMINENT PSYCHIATRIC SYMPTOMS AND GLUCOSE HYPOMETABOLISM IN A FAMILY WITH A SNCA DUPLICATION
Uchiyama, T., Ikeuchi, T., Ouchi, Y., Sakamoto, M., Kasuga, K., Shiga, A., Suzuki, M., Ito, M., Atsumi, T., Shimizu, T., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000327607.28928.e6 · Cited by 34
Considerations for Genomewide Association Studies in Parkinson Disease
Myers, R. H. (2006) · The American Journal of Human Genetics · doi:10.1086/504730 · Cited by 33
Analysis of LRRK2 Gly2385Arg genetic variant in non‐Chinese Asians
Tan, E., Zhao, Y., Tan, L. C. S., Lim, H., Lee, J. H., Yih, Y., Ratnagopal, P., Wong, M. C., Fook-Chong, S. M. C., & Liu, J. (2007) · Movement Disorders · doi:10.1002/mds.21658 · Cited by 32
α-Synuclein gene duplication is present in sporadic Parkinson disease
Troiano, A. R., Cazeneuve, C., Ber, I. L., Bonnet, A.-M., Lesage, S., & Brice, A. (2008) · Neurology · doi:10.1212/01.wnl.0000338435.78120.0f · Cited by 28
Self-citationComprehensive Screening of a North American Parkinson’s Disease Cohort for LRRK2 Mutation
Johnson, J. O., Paisán‐Ruiz, C., Lopez, G. J., Crews, C. K., Britton, A. F., Malkani, R., Evans, E. W., McInerney-Leo, A. M., Jain, S., Nussbaum, R. L., et al. (2007) · Neurodegenerative Diseases · doi:10.1159/000105160 · Cited by 25
Lrrk2 R1628P in non‐Chinese Asian races
Tan, E., Tang, M., Tan, L. C. S., Wu, Y., Wu, R., Ross, O. A., & Zhao, Y. (2008) · Annals of Neurology · doi:10.1002/ana.21467 · Cited by 24
Chan, D. K. Y., Ng, P. W., Mok, V., Yeung, J. H. M., Fang, Z. M., Clarke, R. A., Leung, E. M.-F., & Wong, K. S. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0065-0 · Cited by 22
Möller, J. C., Rissling, I., Mylius, V., Höft, C., Eggert, K. M., & Oertel, W. H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02154.x · Cited by 21
The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany
Schlitter, A. M. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083022 · Cited by 20
Li, Y., Rowland, C. M., Xiromerisiou, G., LAGIER, R. J., Schrodi, S. J., Dradiotis, E., Ross, D. A., Bui, N., Catanese, J. J., Aggelakis, K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002707 · Cited by 18
Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease
Tan, E., Lee, J., Chen, C., Wong, M. C., & Zhao, Y. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.010 · Cited by 18
Eblan, M. J., Scholz, S. W., Stubblefield, B. K., Gutti, U., Göker-Alpan, Ö., Hruska, K. S., Singleton, A., & Sidransky, E. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.032 · Cited by 16
Comparing LRRK2 Gly2385Arg carriers with noncarriers
Tan, E., Fook-Chong, S. M. C., & Zhao, Y. (2007) · Movement Disorders · doi:10.1002/mds.21381 · Cited by 10
Cited by
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
“Approximately 5– 10% of Parkinson cases show a monogenic component with mutations in PARK1, PARK4, PARK5, PARK8, PARK11, and PARK13 associated with an autosomal dominant form, whereas mutations in PARK2, PARK6, and PARK7/DJ-1 are associated with an autosomal recessive form [466].”
Metadata
- Authors
- Lesage, S., & Brice, A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-15
- Volume
- 18
- Issue
- R1
- Pages
- R48-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2156168338
- Cited by
- 945
- References
- 162
- FWCI
- 46.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.